BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16012517)

  • 1. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
    Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
    Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
    Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
    Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of D-type cyclins in normal and neoplastic rat pituitary.
    Qian X; Kulig E; Jin L; Lloyd RV
    Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
    Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
    J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclins D1 and E in human colon adenocarcinomas.
    Sutter T; Doi S; Carnevale KA; Arber N; Weinstein IB
    J Med; 1997; 28(5-6):285-309. PubMed ID: 9604788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
    Kato JY; Sherr CJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11513-7. PubMed ID: 7505440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclin genes in human gastric cancer and in first degree relatives.
    Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
    Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective usage of D-type cyclins in lymphoid malignancies.
    Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
    Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
    Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
    Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of mice expressing a single D-type cyclin.
    Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
    Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon.
    Bartkova J; Thullberg M; Slezak P; Jaramillo E; Rubio C; Thomassen LH; Bartek J
    Gastroenterology; 2001 Jun; 120(7):1680-8. PubMed ID: 11375949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer.
    Skomedal H; Forus A; Holm R
    Anticancer Res; 2003; 23(5A):3929-35. PubMed ID: 14666699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
    Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
    Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
    Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH
    Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and expression of cyclin D3 in human pancreatic cancer.
    Ebert MP; Hernberg S; Fei G; Sokolowski A; Schulz HU; Lippert H; Malfertheiner P
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):449-54. PubMed ID: 11469683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
    Hishida T; Naito K; Osada S; Nishizuka M; Imagawa M
    Biochem Biophys Res Commun; 2008 May; 370(2):289-94. PubMed ID: 18374658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ; Li SA; Tawfik O; Li JJ
    Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
    Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML
    Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 down-regulates the expression of cyclin D during liver development.
    Matsui T; Kinoshita T; Hirano T; Yokota T; Miyajima A
    J Biol Chem; 2002 Sep; 277(39):36167-73. PubMed ID: 12147685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.